The US Food and Drug Administration (FDA) approved the first generic version of fluticasone propionate inhalation aerosol, marketed as Flovent HFA, for maintenance treatment of asthma.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 21 Apr 2026.
The item focuses on FDA Approves New Generic Inhaler for Asthma Treatment.
Review the original article for the full source wording and details.